T. Rowe Price Associates’s XBiotech XBIT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-23,625
| Closed | -$183K | – | 3056 |
|
|
2024
Q3 | $183K | Hold |
23,625
| – | – | ﹤0.01% | 2683 |
|
|
2024
Q2 | $122K | Buy |
23,625
+6,025
| +34% | +$31.1K | ﹤0.01% | 2719 |
|
|
2024
Q1 | $144K | Hold |
17,600
| – | – | ﹤0.01% | 2703 |
|
|
2023
Q4 | $71K | Hold |
17,600
| – | – | ﹤0.01% | 2762 |
|
|
2023
Q3 | $73K | Hold |
17,600
| – | – | ﹤0.01% | 2714 |
|
|
2023
Q2 | $105K | Hold |
17,600
| – | – | ﹤0.01% | 2690 |
|
|
2023
Q1 | $61K | Hold |
17,600
| – | – | ﹤0.01% | 2762 |
|
|
2022
Q4 | $62K | Hold |
17,600
| – | – | ﹤0.01% | 2785 |
|
|
2022
Q3 | $64K | Hold |
17,600
| – | – | ﹤0.01% | 2797 |
|
|
2022
Q2 | $99K | Buy |
17,600
+3,146
| +22% | +$17.7K | ﹤0.01% | 2749 |
|
|
2022
Q1 | $125K | Buy |
+14,454
| New | +$125K | ﹤0.01% | 2803 |
|
|
2021
Q4 | – | Sell |
-12,154
| Closed | -$157K | – | 3039 |
|
|
2021
Q3 | $157K | Hold |
12,154
| – | – | ﹤0.01% | 2765 |
|
|
2021
Q2 | $201K | Buy |
12,154
+340
| +3% | +$5.62K | ﹤0.01% | 2724 |
|
|
2021
Q1 | $203K | Buy |
+11,814
| New | +$203K | ﹤0.01% | 2685 |
|
|
2017
Q4 | – | Sell |
-11,648
| Closed | -$51K | – | 2600 |
|
|
2017
Q3 | $51K | Hold |
11,648
| – | – | ﹤0.01% | 2527 |
|
|
2017
Q2 | $55K | Hold |
11,648
| – | – | ﹤0.01% | 2520 |
|
|
2017
Q1 | $192K | Hold |
11,648
| – | – | ﹤0.01% | 2401 |
|
|
2016
Q4 | $118K | Hold |
11,648
| – | – | ﹤0.01% | 2455 |
|
|
2016
Q3 | $157K | Buy |
+11,648
| New | +$157K | ﹤0.01% | 2383 |
|